Both during embryonic development and as functional components of mature multicellular organisms, indi vidual cells continuously undergo physical changes in appearance, shape, position and contact with extra cellular structures including other cells (BOX 1). These physical changes require cellular motile functions, which are the driving force of many dynamic cell behaviours such as cell migration, guided movement, engulfment, adhesion and contraction. The motile functions of cells are regulated by both physiological and pathological stimuli. The physical basis for cell ular motile functions is provided by macromolecular assemblies, including cytoskeletal scaffold structures of actin micro filaments. These scaffolds undergo dynamic changes in both polymerization and their interaction with specific binding proteins. Regarding the actin microfilament, poly merization of monomeric globular actin (Gactin) into a filamentous actin (F-actin) fibre is influenced by local intracellular concentrations of ATPbound Gactin and by the activity of many actin binding proteins (ABPs). This determines the rate and direction of polymerization, as well as the shape of the newly generated filament 1 . Such dynamic rearrange ments of actin filaments generate the physical force needed for cells to protrude filopodial or lamellipodial membrane extensions and to readjust adhesive contacts, known as focal adhesions, to the cellular environment, as required for motile cell functions.
Although actin microfilament turnover involves the regeneration of depleted ATP-actin levels from ADPactin pools, enabled by the ABP profilin, cell motility also requires the de novo biosynthesis of Gactin. Similarly, activation of protein synthesis is required for the timely generation of other structural components of the actin microfilament network (for example, myosins, actin assembly and disassembly factors, capping proteins and Factin crosslinking proteins) as well as regulatory components (for example, kinases, phosphatases and myosin light chains (MLCs)). Therefore, cell motility requires the tight temporal coupling of actin dynamics and transcriptional activity.
The requirement for the temporal linkage of actin turnover and transcription necessitates signal transduc tion mechanisms that communicate the cyto plasmic actin polymerization status to the nuclear genome. How does the transcriptional machinery sense the need for the biosynthesis of components of both the dynamic actin network and the motility apparatus? To approach this question we first review the various cellular recep tors that are activated by motilityinducing signals and subsequently lead to activation of the central intra cellular regulatory proteins of the Rho family of GTP binding proteins (FIG. 1) . We then focus on relay systems that enable dynamic rearrangements of the cytoskeletal actin microfilament to be communicated to the nucleus by release and nuclear translocation of specific ABPs, thereby eliciting defined changes in the expression of specific gene profiles (FIG. 2) .
General influences of nuclear actin and nuclear ABPs on overall gene expression are not discussed in detail. instead, this review emphasizes recent insights into the specific function of Gactin to control both nucleus-cytoplasm shuttling and the nuclear activity of transcriptional cofactors of the myocardin protein family (myocardin itself, plus the myocardinrelated transcrip tion factors (MRTFs)) (FIG. 3) . These proteins, in turn, control the activity of serum response factor (SRF), a nuclear transcription factor. Thereby, the cytoplasmic concentration of Gactin is reflected by the concentration of MRTF retained in the cytoplasm and is a direct measure of actin dynamics. The release and nuclear translocation of cytoplasmic MRTF on actin polymer ization elicits SRFdirected target gene activation. Thereby, the actin-MRTF-SRF circuit allows for the precise modulation of gene expression in concert with cytoskeletal assembly and disassembly. Since SRF target genes encode structural components of the microfila ment (for example, actin itself) and regulators of actin dynamics (for example, gelsolin and vinculin), as well as microRnAs (miRnAs) that provide feedback regu lation in these pathways, the MRTF-SRF circuit assumes cen tral importance in directing essential gene activities required for the execution of motile cell functions.
Signal regulation of actin dynamics
The diverse cellular motile functions (BOX 1) are elic ited by a host of extracellular stimuli. These stimuli are perceived by cognate receptor proteins that acti vate different members of the Rho GTPase family through selective Rho guanine nucleotide exchange factors (GeFs) (FIG. 1) . The Rho GTPases encompass members of the Rho, Rac and Cdc42 subfamilies 2 , which regulate effector proteins that modulate the polymerization equilibrium of Gactin and Factin in the cytoplasm. Gactin forms complexes with dif ferent ABPs, including the nucleating factors profilin, formins and the actinrelated protein 2/3 (ARP2/3) complex 1, 3 . Activation of Rho GTPases promotes actin polymerization by two downstream signalling modules, one involving the Rhoassociated kinase (RoCK)-LiM kinase-cofilin pathway (cofilin is an ABP that can stimulate actin depolymerization and thereby enhance actin poly merization elsewhere), and the other medi ated by formin (such as Diaphanousrelated formin (DRF)) ABPs. experimentally, actin dynamics can be effectively modulated using clostridial toxins and other actintargeting natural compounds 4 
As outlined in FIG. 1 , several types of plasma mem brane receptors modulate actin polymerization and cell ular motility by modulating Rho GTPase activity. in the examples discussed below, the link between these receptors and the MRTF-SRF module is emphasized.
Signalling by G protein-coupled receptors. G protein coupled receptors (GPCRs) are a large family of mem brane receptors displaying seven transmembrane helical domains that can couple to heterotrimeric G proteins (guanine nucleotidebinding proteins; consisting of α, β, and γsubunits). Heterotrimeric G proteins with Gα subunits of the types Gα 12/13 , Gα q/11 and Gα i/0 contribute to actin turnover by engaging Rho GTPases 5 
(FIG. 1).
GPCRs interact with many ligands, including hormones, chemokines, bioactive lipids, gastrointestinal peptides,
Box 1 | Motile functions of cells
The living eukaryotic cell must be viewed as a dynamic structure experiencing frequent changes in macromolecular contacts, signal inputs and metabolic flux. As a consequence, cells display continued physical rearrangement and adjustment. Such motility functions require supporting intracellular counter-forces, as generated by dynamic rearrangements of the actin microfilament. Polymerization of monomeric globular actin (G-actin) into filamentous actin (F-actin) polymers is reversible and both reactions are facilitated by numerous actin binding proteins (ABPs).
Cellular motile functions involving dynamic actin microfilament rearrangements include cell migration, spreading, adhesion, contraction and polarization, cell-cell contact and cell-extracellular matrix (ECM) interactions (see the figure) . These microfilament rearrangements result in the processes of chemotaxis, mechanotaxis (cell stretching and overload), maintenance of cellular tone, shape changes (branching), engulfment (by phagocytosis), neurite or vascular tip cell extension, axon guidance, morphological rearrangements (such as those required for epithelial-mesenchymal transitions) and intracellular transport (such as RNA localization, protein delivery, membrane trafficking, endocytosis, internalization, secretion and organelle positioning).
Dynamic changes of the actin microfilament contribute to each of these motile functions, either as structural components or as platforms for signal transduction. Microfilament polymerization and depolymerization, accompanied by the association and dissociation of interacting molecular structures, provide the physical scaffold for dynamic changes underlying motility. As discussed in this review, the multitude of cell behaviours involving actin dynamics requires gene expression and de novo protein biosynthesis. Selected ABPs function as courier proteins to communicate to the cellular genome the state of actin rearrangements. Such transcriptional relay systems modulate the expression of genes that encode products which contribute to either the execution or regulation of cellular motility functions. Actin structures are indicated in the figure in different shades of red. Image is reproduced, with permission, from Nature Cell Biology REF. 142 . Many of these receptors have essential influences on motile cell functions. Activation of the actin-MRTF-SRF pathway has been shown by veGF receptor signal ling in endothelial cells 10 , ephA signalling in neurons 11, 12 and neurotrophin signalling in dorsal root ganglia (prob ably through the TRKA, TRKB and TRKC receptors) 13 . The central importance of SRF signalling in these types of signalling events is exemplified by the abnormalities in vasculogenesis 14, 15 , neuronal axon guidance and synaptic targeting 11, 13, 16 in Srf knockout mice.
Integrin signalling. integrin receptors link cells to the extracellular matrix (eCM) and are the main structural organizing components of focal adhesions. integrin signalling has a big impact on the reorganization of the actin cytoskeleton. integrinmediated actin dynamics is pri marily achieved by activating the RHoA and RAC1 GTPases, which involves the regulation of Rho GeFs by the kinases integrinlinked kinase (iLK), focal adhesion kinase (FAK) and SRC 17 (FIG. 1) . integrins also commu nicate external and internal mechanical stress to the actin cyto skeleton. Such mechanosensing was shown to activate the actin-MRTF-SRF pathway 18 .
TGFβ signalling. The transforming growth factorβ (TGFβ) superfamily of cytokines includes TGFβfamily polypeptides, bone morphogenetic proteins (BMPs) and activins. These ligands act through heterotetrameric complexes of Ser/Thr kinase receptors, which activate different signalling pathways and, in addition, modulate Rho GTPasemediated actin dynamics 19 . TGFβinduced alterations in cellular architecture and motility contribute to cellular epithelial-mesenchymal transitions (eMT), which are biologically linked to embryonic tissue move ments and to tumour cell invasiveness and metastasis. Activation of the MRTF-SRF module was observed on TGFβ [20] [21] [22] and BMP signalling 23 .
E-cadherin signalling. epithelial cell-cell junctions (adherens junctions) are mediated by homophilic inter actions of epi thelial cadherins (ecadherins). Cadherins are function ally linked to the actomyosin cytoskeletal scaffold through catenins 1 . Assembly and disassembly of cell-cell contacts both requires and elicits extensive actin dynamics and acti vates the MRTF-SRF pathway through the GTPase RAC1 (REFs 20, 24, 25) . The dis assembly of epithelial cell contacts is an initiating event in eMT. The release of catenins (αcatenin, βcatenin and p120catenin) activates actin dynamics and can directly modulate nuclear protein function 26 .
Non-canonical Wnt signalling. The noncanonical, βcateninindependent Wnt-planar cell polarity (PCP) signalling pathway uses the Wnt signalling component Dishevelled to activate regulators of actin dynamics, . This triggers expression of a subset of SRF target genes, namely cytoskeletal genes. b | Activation of SRF class II target genes. Nuclear MRTF can be complexed by nuclear G-actin, which inhibits MRTF-mediated stimulation of SRF-dependent transcription and facilitates MRTF nuclear export 76 . SRF class II target genes that are transcribed as a result of MRTF-SRF activation include actin itself and many genes that modulate actin dynamics, such as gelsolin and vinculin. These newly made proteins, with increasing time and concentration, might stimulate cytoplasmic actin polymerization, complex cytoplasmic MRTF or elevate levels of nuclear G-actin to downregulate MRTF-mediated transcription and stimulate nuclear export of MRTF. 
Heterotrimeric G protein
One of a family of heterotrimeric cytoplasmic signal mediators composed of an α-subunit containing a GTP-binding site and intrinsic GTPase activity, together with a hydrophobic and an often acylated β-and γ-protein subcomplex. The β-and γ-protein subcomplex may be activated by the dissociation of α-GTP, which is initiated by GTP exchange on the α-subunit.
Epithelial-mesenchymal transition
The transformation of an epithelial cell into a mesenchymal cell with migratory and invasive properties.
including the Rho, Rac and Cdc42 GTPases, RoCK 27 and the forminrelated protein Dishevelledassociated activator of morphogenesis 1 (DAAM1) 28. This pathway was originally identified in Drosophila melanogaster in the establishment of spatial tissue organization, specifi cally the planar cell polarity of pupal fly wing cells 29 . in vertebrates, Wnt signalling modulates actin dynamics for polarized cell movements during gastrulation and organogenesis 30 . The link of Wnt-PCP signalling to the MRTF-SRF relay is still hypothetical.
Microfilament-to-genome relay systems in this section, we review the range of currently charac terized mechanisms by which cells communicate the dynamic status of their actin microfilaments to the genome.
Cytoplasmic actin dynamics cause changes in both Gactin concentration and Factin structure; the latter can, in turn, lead to an altered structure or composition of Factin complexes (FACs), such as focal adhesion com plexes. Actin is recognized by ABPs, which, for clarity, we suggest are classified here as Gactin binding proteins (GABPs), Factin binding proteins (FABPs) and Factin complexassociated proteins (FACAPs) (FIG. 2) .
Conceptually, changes in actin dynamics may be communicated to the genome in three ways. First, changes in cytoplasmic monomeric Gactin concen trations can elicit corresponding changes in nuclear Gactin levels. Second, changes in cytoplasmic mono meric Gactin levels can be sensed by GABPs, whereby polymerization of Gactin into Factin can result in the release of GABPs, their nuclear translocation and the subsequent modulation of nuclear transcription factors (FIG. 2) . This mechanism is best characterized by the MRTF-SRF circuit (FIG. 1; FIG. 3) . Last, the status of cytoplasmic actin dynamics can be scored directly by cellular sensors of Factin filament structure and density. Thus, architectural rearrangements of cyto plasmic Factin fibres can lead to the release of FABPs or FACAPs, followed by their nuclear translocation (FIG. 2) . in the following section, we provide a brief over view of different relay systems linking actin dynamics to transcriptional genome activity, according to the mechanisms conceptualized above.
Nuclear actin and ABPs. nuclear actin, in both mono meric Gactin and polymeric Factin forms, profoundly affects transcriptional responses in general terms 31, 32 . it influences gene expression by at least three mecha nisms: actin is a component of all three types of RnA polymerases (classes i, ii, and iii), it contributes to ATP dependent chromatin remodelling and it binds differ ent ribonucleoprotein (RnP) complexes in eukaryotic cell nuclei, including small nuclear RnAs (snRnAs) and heterogeneous nuclear RnAs (hnRnAs). in these activities, actin functions jointly with both GABPs and FABPs. Gactin can enter and exit nuclei by diffusion; however, use of its nuclear export sequence, partly in conjunction with members of the exportin protein fam ily or with profilin, regulates its export. This controls the nuclear exit of other GABPs, such as MRTFs, which are exported bound to Gactin (see below).
JNK signalling. Signals that elicit dynamic actin re arrangements on activation of Rho GTPases, like the abovementioned noncanonical Wnt-PCP path way, were shown to also result in the activation of the Jun nterminal kinases (JnKs) [33] [34] [35] , which regulate gene transcription. in different experimental settings, GTPasemediated JnK activation involved mediation by the kinases mixed lineage kinase 3 (MLK3; also known as MAP3K11) 36 and RoCKs
37
, or the adaptor protein CRK 38 . it remains to be shown unequivocally that such mechanisms of JnK activation strictly correlate with the stimulation of actin dynamics.
NF-κB signalling. Cytoplasmtonucleus translocation of the transcription factor nuclear factorκB (nFκB) can be elicited by regulators of actin dynamics. expression in endothelial cells of intercellular adhesion molecule 1 (iCAM1), on stimulation by thrombin, involves RHoARoCKmediated activation of nuclear nFκB 39 . Also, disruption of epithelial cell-cell contacts and associated actin reorganization leads to RHoA-RoCKmediated activation of protein kinase D (PKD1), resulting in the 31, 32 , and examples of F-ACAPs include ABL1, integrin cytoplasmic domain-associated protein 1 (ICAP1α), LIM domain proteins and p120-catenin 44 . The shuttling LIM domain proteins zyxin, lipoma-preferred partner (LPP), Cys-rich proteins (CRPs), Hic-5 (also known as TGFB1I1), antileukoproteinase (ALP), paxilin and LIM and SH3 domain protein 1 (LASP1) were shown to directly bind F-actin, whereas LIM kinase, particularly interesting new Cys-His protein 1 (PINCH; also known as LIMS1) and four and a half LIM domains protein 2 (FHL2) are probably indirectly linked to F-ACs 44, 45 . F-ACs assemble at the cytoplasmic sides of focal adhesions, cadherin-mediated cell-cell adherens junctions and cell-cell tight junctions. TF, transcription factor. activation of nFκB 40 . This scenario may reflect loss of cell-cell contacts during pathological stimulation of endothelial cell motility.
Nuclear hormone receptors. nuclear hormone receptors, specifically the androgen receptor (AR), are modulated in their transcriptional activity by actin and ABPs, in addition to being under the control of their cognate hormone ligand. Regulation of AR by FABPs and GABPs can be exerted at the level of cytoplasmtonuclear trans location, or by influencing the trans criptional activity of a promoterbound receptor. ABPs shown to interact with the AR include gelsolin, αactinin 2, super villlin, filamin and transgelin 32 . Gactin is part of the AR transcription complex.
The DNA damage response, Nck and JMY. Genotoxic insults affect actin dynamics and elicit transcriptional responses 41, 42 . DnA damaging treatment with ultraviolet (uv) light causes two cytoplasmic ARP2/3 effector pro teins, junctionmediating and regulatory protein (JMy) and the nCK1-suppressor of cytokine signalling 7 (SoCS7) complex, to translocate to the nucleus. JMy is a GABP that can stimulate cell motility. on nuclear translocation, JMy acts as a cofactor of the p53-p300 complex to stimulate the transcription of proapoptotic genes 41 . nuclear translocation of nCK1-SoCS7 follows uvinduced separation from septin proteins 43 , which act as FABPs. Activation of the DnA damage checkpoint response requires an as yet undefined nuclear function of nCK1. This highlights new facets of actin micro filamant togenome communication that specifically contribute to the cellular genotoxic stress response.
LIM domain-containing proteins. integrinmediated engagement of cell-eCM contacts at focal adhe sions causes the nuclear translocation of cytoskeletal FACAPs 44, 45 . The best studied examples are LIM domain containing proteins and include zyxin, lipomapreferred partner (LPP), thyroid receptorinteracting protein 6 (TRiP6), paxilin, Hic5 (also known as TGFB1i1), Cysrich protein 1 (CRP1), CRP2, antileukoproteinase (ALP), four and a half LiM domains protein 2 (FHL2), LiM and SH3 domain protein 1 (LASP1) and partic ularly interesting new Cys-His protein 1 (PinCH; also known as LiMS1). These proteins engage in the forma tion of protein-protein assemblies at focal adhesion associated actin fibres and, alternatively, can act as nuclear cofactors of transcription or as regulators of nuclear mRnA export. interestingly, some of these LiM proteins are either cofactors of the transcription factor SRF (for example FHL and CRP proteins) 46, 47 or are encoded by SRFregulated genes (for example zyxin and FHL2) 47, 48 . The precise mechanisms of liberation The MRTF-SRF circuit The appreciation that the transcription factor SRF is subject to regulation by Rho GTPases 49 and actin dynamics 50,51 provided the first clue to a hitherto unde tected link between the actin cytoarchitecture and gene activity. Subsequent identification of Gactinregulated nucleus-cytoplasm shuttling of the SRF cofactors, MRTFs, revealed for the first time a direct mechanism enabling cytoplasmic Gactin to control nuclear tran scriptional activity 52 . MRTFs are GABPs, and this regulatory system seems to be of prime importance for the fuelling of actinbased cellular motile function. Thus, the remainder of this Review concentrates on the MRTF-SRF circuit.
Molecular and biological functions of SRF. SRF is a versatile transcription factor, encoded by a single gene that is abundantly expressed in many cell types 53, 54 . SRF homologues are found in all species investigated, ranging from yeast to humans. Homodimeric SRF binds with high affinity and specificity to the palindromic CC(A/T) 6 . SRF target genes fulfil essential functions (see below), explaining, in part, the dramatic phenotypes seen on Srf deletion in mice 73 . A broad range of biological processes is supported by SRF, including gastrulation, develop ment and function of the heart and the cardiovascular system, functioning of all three types of muscle cells, endothelial cell biology and vascularization, develop ment and regeneration of the liver, T cell and B cell activities of the immune system and neuronal func tions of the developing and adult brain. At the cellular level, many of these phenotypes can be attributed at least in part to impaired functioning of the actin micro filament 48 . Given the importance of SRF in regulating actin cytoskeletal dynamics, there are nevertheless func tions of SRF that go beyond the transcriptional control of cytoskeletal target genes, including contributions to cell survival and apoptosis.
Molecular and biological functions of MRTF proteins.
Myocardin, the founding member of the MRTF family (FIG. 3) , is expressed specifically in the cardiovascular system 66-68 , whereas other MRTF family members dis play more widespread expression patterns. Myocardin shares homology with MRTFA (also known as MAL, MKL1 and BSAC) and MRTFB (also known as MKL2 and MAL16) in a series of conserved domains; to har monize the nomenclature we suggest using the MRTF designation, which is based on homology criteria of the gene family 69 . These potent transcriptional coactivators associate with SRF through a basic region and an adjacent Glurich domain (FIG. 3) .
Box 2 | In vitro modulators of actin dynamics and MRTF-SRF activity
Elucidation of the myocardin-related transcription factor (MRTF)-mediated communication between actin dynamics and transcriptional activation has been helped greatly by the use of compounds that modulate actin activity 51, 52, 75, 76 . The effect of Rho GTPases on actin polymerization can be inhibited by clostridial toxins such as the RHOA inhibitor C3 transferase (ADP-ribosytransferase) or by the Rho-associated kinase (ROCK)-inhibiting substance Y-27,623 (see the figure, part a) . Actin . Nuclear G-actin also complexes with MRTF, thereby inhibiting the activation potential of serum response factor (SRF) and stimulating nuclear export of MRTF (see the figure, part d) . Nuclear MRTF-G-actin complexes 76 are affected by actin-targeting compounds in a smilar manner to cytoplasmic complexes. Importantly, these studies reveal that many compounds that were previously thought to primarily modulate actin polymerization equilibrium, also influence the stabilities of actin-actin binding protein (ABP) complexes.
Mutant variants of actin have also been useful in studying the MRTF-dependent regulation of SRF. Actin variants Glu13Arg and Arg62Asp are impaired in polymerization and therefore inhibit MRTF activity, whereas Val159Asn and Ser14Cys stimulate F-actin formation and activate MRTF function 50 . Glu15Ser also stabilizes F-actin while also apparently interacting more tightly with MRTF and promoting its nuclear entry 75 . MRTF variants defective in interacting with actin display constitutive nuclear localization 74 . Structural information on MRTF-G-actin was provided recently by co-crystallization of MRTF-derived RPEL peptides and G-actin in the presence of latrunculin B 77 .
RPEL domain
A protein domain containing the amino acid sequence ArgPro-X-X-X-Glu-Leu that is found triplicated in the myocardin family of transcriptional coactivators. RPEL domains form stable complexes with G-actin.
The aminotermini of MRTFs contain three RPEL domains, which form a stable complex with monomeric Gactin 52, [74] [75] [76] [77] , resulting in the sequestration of MRTFs in the cytoplasm. Myocardin contains divergent RPeL domains that do not bind actin efficiently; consequently, homodimeric myocardin is constitutively nuclear and insensitive to cellular stimuli that modulate actin polymer ization 68, 78 . However, heterodimerization between myocardin and other MRTFs has been proposed to facilitate cooperativity between CArG boxes in SRF regulated muscle genes 79 . Thereby, myocardin might be subjected indirectly to the regulatory mechanisms operating on MRTFs, specifically Gactin binding.
Knockout studies of myocardin (Myocd) and MRTF genes in mice have shown that these SRF coactivators are uniquely required in vivo in different cell types and at different developmental stages. nearly all of the Myocd mutant phenotypes reflect abnormalities in aspects of motile cell functions and regulation of SRFdependent contractile and cytoskeletal genes [80] [81] [82] . Mice lacking MRTFA are viable, but females are unable to nurse their offspring owing to impairments in mammary myoepithelial cells 83, 84 . The global deletion of MRTFB results in embryonic lethality owing to cardiovascular defects, including abnormal patterning of the branchial arch arteries, a doubleoutlet right ventricle, ventricular septal defects and a thinwalled myocardium nuclear Gactin also modulates MRTF functions in multiple ways 76 . First, nuclear export of MRTFs is facili tated by nuclear Gactin. Second, nuclear Gactin pre vents nuclear MRTF from activating SRF target genes, so that liberation of the nuclear actin-MRTF complex is required to stimulate SRF. Thus, cellular Gactin regulates MRTFs at three levels: nuclear import, nuclear export and nuclear activation or inactivation of MRTFSRFdependent transcription 76 (FIG. 1b) . it has also been suggested that MAPK phosphorylation of MRTF stim ulates its nuclear export by enhancing the inter action of MRTF with nuclear actin 86 . Therefore, in light of the actin genes themselves being under MRTF-SRF control, a Gactindependent, kinetically tuned autoregulatory feedback loop emerges for Rhodirected control of tran scription mediated by MRTF-SRF. Rho activates the ini tial synthesis of Gactin and ABPs to stimulate Factin polymerization in the cytoplasm as stimuluselicited cell biological requirements dictate. With ongoing actin synthesis, Gactin levels rise in both the cytoplasm and the nucleus, thereby downregulating the SRF response by simultaneously impairing the nuclear function and facilitating the export of nuclear MRTF, and by en suring efficient retention of cytoplasmic MRTF (FIG. 1) .
Accordingly, nucleus-cytoplasm shuttling of MRTF is an essential component of this actindirected feedback circuit.
The above regulatory mechanisms have been described most thoroughly in muscle cells and cultured fibroblasts. By contrast, in primary neurons a constitu tiv ely high nuclear level of MRTF is seen in the absence of stimuli. it will be interesting to identify modulators influencing nuclear MRTF activity in neurons and to explore the potential contributions of nuclear actin 12, 76 and nuclear MRTF phosphorylation 86, 87 to the neuronal functions of MRTFs.
Positive and negative regulators of MRTF-SRF activity.
numerous cofactors in addition to TCFs and MRTFs exert positive and negative effects on SRF activity. in the cytoplasm of muscle cells, striated muscle activator of Rhodependent signalling (STARS; also known as ABRA) is a GABP that is upregulated during cardio myopathy 88 . STARS is localized to the sarcomere and, by interacting with monomeric Gactin, promotes nuclear translocation of MRTFA. STARS thereby syner gizes with MRTFA to stimulate SRFmediated transcrip tion. Positive nuclear cofactors of SRF include the nkx25 family of homeodomain proteins 89 , members of the GATA family of zincfinger proteins 90, 91 and the CRP family of Cysrich LiMonly proteins 46 . negative co factors include the LiMonly protein FHL2 (REFs 47,92), histone deacetylase 4 (HDAC4) 93 , the homeo domain protein MSX1 (REF. 94 ) and the zincfinger protein krueppellike factor 4 (KLF4) 95 . Homeodomainonly protein (HoP) dampens SRF activity in cardiac muscle cells by competing with it for myocardin and MRTFA interaction, and also by recruiting HDAC2 to SRF target genes [96] [97] [98] . Members of the myocardin family also engage various partners in addition to or in conjunction with SRF. These include the histone acetyltransferase p300 (REFs 99,100), class ii HDACs 99 , SMAD4 (REF. 101 ) (a transcription factor regulated by TGFβ signalling), forkhead box protein o4 (FoXo4) 95 and GATA trans cription factors 102 . Such combinatorial associations of SRF with positive and negative partners expand the regulatory potential of SRF by providing cell type specificity, temporal control and signal responsiveness to SRF target genes. 47, 48, 59, 60 (for review see REF. 57 ). Based on these studies, we esti mate the number of SRF target genes to be around 300. Chromatin immunoprecipitation (ChiP) with antiSRF antisera, which provides stringent support for direct gene regulation by SRF, has identified more than 200 SRF target genes 103 . Selective cofactor recruitment (TCF versus myo cardin and MRTFs) directs signalspecifi c regulation of different classes of SRF target genes. Class i target genes, which primarily encode proteins with 'immediate-early' cellular functions, including the rapid transcriptional activation of genes encoding proteins involved in the G0-G1 transition, are aided by TCF cofactors 62, 63 . Class ii target genes, which are regulated by SRF in conjunction with myocardin or other MRTF cofactors 57 , encode at least three types of proteins, namely those involved in musclespecific and contractile functions, actin microfilament dynamics and cell motility, and miRnA activities. in the following, we restrict our discussion to class ii SRF target genes to emphasize their regulation by the myocardinfamily transcriptional coactivators.
MRTF-SRF target gene functions
Muscle-specific and contractile genes. nearly all smooth musclespecific genes and many cardiac and skeletal muscle genes are controlled by CArG boxes. Myocardin is a particularly potent activator of SRFdependent smooth muscle gene expression 79, 84, [104] [105] [106] . Forced over expression of MRTFs also activates smooth muscle genes in transfected cells, which raises the question of why the endogenous levels of MRTF in many non muscle cells are not sufficient to drive the expression of muscle genes 59, 69, 107, 108 . it is likely that endogenous MRTF levels are regulated by actin signalling, whereas overexpressed MRTFs bypass this regulatory mechanism to directly activate downstream muscle genes. MRTFs are also required for skeletal muscle differentiation, as shown by the inhibition of skeletal muscle gene expres sion on expression of dominantnegative MRTF mutants in vivo and in vitro 59, 108 . Many of the contractile func tions of muscle cells are enabled by myocardin-SRF and MRTF-SRFregulated genes 57 .
Genes affecting actin dynamics and cell motility. SRF tar get genes, which are regulated on recruitment of MRTF cofactors, encode proteins related to actin cytoskeletal activities. SRFregulated gene products can be grouped into three categories according to their contributions to actin microfilament function: structural (for example, actin), effectors of actin turnover (for example, cofilin 1) and regulators of actin dynamics (for example, talin 1). TABLE 1 lists some wellcharacterized examples of cytoskeletal SRF target genes. in biological terms, the encoded proteins contribute to development (meso dermal patterning), functioning of the contractile apparatus (muscle cell contraction, vascular tone) and eCMmediated adhesion and tissue remodelling.
expression profiling using modulators of MRTF activity (dominantnegative MRTF and treatment with cytocalasin D in the absence or presence of latrunculin B; see BOX 2) identified a subset of ~ 30 MRTFdependent SRF target genes 7, 59, 109 . We expect this number to grow with ongoing investigations 110 . ChiPbased evidence for the association of MRTF with SRF at CArG boxes is available but is limited 103 . Despite this limitation, iden tified MRTFdependent SRF target genes contribute to cell-eCM adhesion and actomyosin activity. Many structural components of focal adhesions are encoded by SRF-MRTFregulated genes, including α1, α5, α9 and β1 integrins, as well as talin 1, vinculin, and the syndecan proteins 2 and 4 (REF. 57), such that SRF deficiency leads to impaired formation of focal adhesions 48 .
miRNAs. Recent studies have revealed central roles for miRnAs in the cellular circuitry through which SRF and MRTFs control muscle gene expression, cytoskel etal dynamics and stress responsiveness 111 . SRF directly activates the expression of two bicistronic miRnA genes that encode pairs of homologous miRnAs (miR11 and 
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These miRnAs, in turn, regulate a large collection of mRnAs, many of which encode proteins that impinge on the SRF-MRTF signalling pathway. miR133, for example, represses the expression of SRF, thereby establishing a negative feedback loop to precisely titrate SRF expression in muscle cells 113 . A particularly intriguing finding is that miR1 can substitute for SRF in the induction of mesoderm from mouse embryonic stem cells 114 . A screen for miRnAs regulated by MRTFA in car diac myocytes identified several miRnAs with key roles in muscle differentiation, proliferation and phenotypic switching 115 . Many of the same miRnAs were down regulated in SRFnull compared to wildtype mouse embryonic stem cells. Bioinformatics also showed a dis proportionate number of predicted SRFbinding sites associated with miRnA genes 116 . miR143 and miR145 are encoded by a bicistronic miRnA gene, controlled by a distal upstream CArG box (FIG. 4b) . These two miRnAs are expressed in early car diac progenitors and throughout the embryonic heart before becoming restricted to all vascular and visceral smooth muscle cells 115, 117 . miR145 knockdown in cul tured cells was reported to block smooth muscle gene activation by myocardin, pointing to this miRnA as an essential cofactor of myocardin 117, 118 . By contrast, knock out mice lacking miR143, miR145 or both are viable and express smooth muscle SRF target genes normally 115 . However, these mice are resistant to vessel remodelling in response to vascular injury. The insensitivity of these mutant mice to vascular injury seems to reflect abnor mal regulation of a collection of proteins involved in the modulation of actin cytoskeletal dynamics and stress fibre formation, rendering the mutant mice insensitive to deformation of the vessel wall. For example, these miRnAs target adducin 3, which caps barbed ends of actin filaments and acts as a bridge between the mem brane and actin cytoskeleton 115 . Slingshot 2, another target of miR143 and miR145, promotes cell motility and enhances Factin reorganization by dephosphory lating and activating cofilin, an actin severing factor. miR145 targets KLF4 and KLF5, which repress SRF activity, as well as SlitRobo GTPaseactivating proteins, which modulate cell migration by inactivating the small GTPase Cdc42 and inhibiting actin polymerization 115 . Finally, these miRnAs target MRTFB, the upstream reg ulator of their expression, providing a negative feedback loop to precisely titrate miR143 and miR145 expression and actin dynamics 115 (FIG. 4b) .
Mice lacking miR143 and miR145 display a reduc tion in blood pressure owing to a decreased vascular tone. These findings point to a role for miR145, and to a lesser extent miR143, in the control of a feedback loop that modulates a cytoskeletal-transcriptional circuit regulated by SRF. miR-133a inhibits SRF expression, establishing a precisely titrated feedback loop to modulate SRF activity. There are two clusters of miR-1 and miR-133a genes in mammalian genomes, which are expressed specifically in cardiac and skeletal muscle cells. A third homologous pair of miRNAs, miR-206 and miR-133b, is expressed specifically in skeletal muscle independently of SRF. Genetic deletion of miR-1 results in phentoypes that suggest it has a role in mesoderm formation. Genetic deletion of the two miR-133a genes results in perinatal lethality owing to cardiac defects. miR-1 and miR-133a also repress neuroectoderm and endoderm genes and promote mesoderm gene expression. miR-1 can substitute for SRF to regulate downstream genes involved in mesoderm development by an undefined mechanism. b | Regulation of miR-143 and miR-145 by SRF. SRF activates transcription of a bicistronic miRNA cluster encoding miR-143 and miR-145, which are expressed specifically in cardiac and smooth muscle cells 115, 117 . These miRNAs, regulate the expression of numerous mRNAs encoding regulators of actin signalling and myocardin-related transcription factor (MRTF)-SRF activity, thereby establishing an elaborate series of feedback loops to modulate the actin-MRTF-SRF signalling pathway. Targets of miR-143 or miR-145 include the zinc-finger proteins krueppel-like factor 4 (KLF4) and KLF5 (which inhibit SRF), MRTF-B, slingshot 2 phosphatase (SHH2; which controls actin polymerization by cofilin phosphorylation), adducin 3 (which promotes actin polymerization) and Slit-Robo Rho GTPase-activating protein 1 (SRGAP1) and SRGAP2 (which inhibit Rho signalling) 115 . This pathway has been shown to be essential for vascular remodelling in response to injury. In the absence of miR-143 and miR-145, actin stress fibre formation is disrupted, rendering smooth muscle cells insensitive to mechanical stimuli that typically cause vascular stenosis.
Leiomyosarcoma
A rare type of cancer (a soft tissue sarcoma) that is a malignant neoplasm of smooth muscle origin.
Another miRnA regulated by SRF together with MRTF is miR486, a cardiac and skeletal muscle enriched miRnA expressed from an alternative prom oter in an intron of ankyrin 1 (REF. 119 ). miR486 acts as a downstream effector for the SRF-MRTF pathway and promotes phosphoinositide 3kinase (Pi3K)-AKT signalling by inhibiting the expression of phosphatase and tensin homologue (PTen) and FoXo1A, which act as negative regulators of Pi3K signalling.
By regulating the expression of miRnAs that affect the signalling system which controls MRTF-SRF activity, the MRTF-SRF partnership generates a balanced regu latory network to govern cytoskeletal function and sig nal responsiveness. it is curious that SRF, more so than other transcription factors, is so tightly intertwined with miRnA regulatory circuits. Perhaps this reflects the importance of maintaining tight control over SRF and its downstream targets.
The actin-MRTF-SRF circuit in pathology MRTFmediated communication between the actin cytoskeleton and the genome has broad implications for many motile functions of cells. Cell typespecific mouse knockout studies of Srf and MRTF genes sug gest that the MRTF-SRF circuit contributes to human pathology. Available evidence supporting this notion is discussed below in the context of two major threats to human health: cardiovascular diseases and cancer. Cardiovascular diseases. Given the plethora of genes encoding contractile proteins that are regulated by SRF and members of the myocardin family, it is not sur prising that this regulatory pathway has a central role in force and mechanosensing of muscle cells, such that dysregulation of SRFdependent gene expression contributes to numerous disease models of the cardio vascular system. During pathological remodel ling of the heart in the settings of hypertrophy and heart failure, SRFdependent genes are dysregulated. STARS and myocardin, two positive modulators of SRF func tion, are upregulated during cardiomyopathy and hypertrophy, respectively 88, 120, 121 . Caspase 3 cleavage of SRF in a failing heart generates a dominantnegative form of SRF that may suppress expression of sarco meric genes 122 . Thus, SRF is not only required for the appropriate expression of cardiac contractile proteins, but excessive SRF is pathogenic, indicating the require ment of MRTF-SRF activity for cardiac homeostasis. This may explain why miRnAs, which provide robust ness and stability to gene regulatory programmes, are so intimately integrated into the MRTF-SRF signalling pathway.
Recently, SRF and myocardin were shown to be over expressed in small cerebral arteries during Alzheimer's disease, and to have a key role in the progression of the disease by enhancing arterial hypercontractil ity through the activation of SRFdependent smooth muscle contractile genes, thereby diminishing cerebral blood flow 123 . in addition, SRF and myocardin control amyloidβ peptide clearance from cerebral vascular smooth muscle cells 124 .
SRF also functions as a central regulator of smooth muscle cell phenotypes in response to injury and con tributes to pathological smooth muscle cell prolifera tion in the vessel wall. Signals that diminish myocardin and MRTF activity promote excessive proliferation of smooth muscle cells, as occurs during atherosclerosis and restenosis 125 . The forkhead transcription factor FoXo4 and the zincfinger protein KLF4 are upregulated during de differentiation of vascular smooth muscle cells in vivo 95 , resulting in suppression of SRFdependent transcription. Thus, the MRTF-SRF circuit functions as a nodal sen sor of mechanical stress and growth factor signalling to modulate phenotypic switching of smooth muscle cells.
Cancer. Associations of the actin-MRTF-SRF circuit with human cancer biology have been identified, sug gesting an MRTF-SRF involvement in the neoplastic process. However, definitive evidence for causative links to clinically relevant carcinogenesis is still lacking.
infant acute megakaryoblastic leukaemia (AMKL), which correlates with poor prognosis, is associated with the balanced chromosomal translocation t(1;22) (p13;q13), in which the MRTFA gene (MKL1; also known as MAL) is fused to the genomic fusion partner oTT (also known as RBM15) [126] [127] [128] (FIG. 3) . oTT-MAL is a constitutively nuclear, deregulated activator of SRF, which is not subject to control by Gactin [129] [130] [131] . oTT-MAL activates the transcription factor Jκ recombination signalbinding protein (RBPJκ), which is normally con trolled by canonical notch signalling and is overridden by oTT-MAL to cause abnormal megakaryopoiesis 132 . Myocardin was argued to be a differentiation inducing tumour suppressor protein that is downregu lated in mesenchymederived sarcomas 133 . By contrast, leiomyosarcoma (LMS) smooth muscle tumours display overexpression of myocardin 134 . in human prostate cancer, androgen receptor activity was suggested to regu late SRFdependent expression of FHL2 (REF. 135 ), which itself is a regulator of SRF activity 47, 92 and integrin sig nalling; the expression of either SRF or FHL2 correlates with poor prognosis.
The general association of MRTF-SRF activity with actinregulated cellular motile functions links actin-MRTF activity to cancer metastasis. Accordingly, deple tion of either MRTF or SRF caused reduced adhesion, spreading, motility, invasion and colonization of meta static tumour cells in an experimental in vivo metastasis assay 109 . in support of MRTF-SRF activity contributing to tumour metastasis, suppressor of cancer cell inva sion (SCAi) was found to repress MRTF activity. SCAi was postulated to downregulate MRTF-SRFmediated expression of β1 integrin, thereby acting as a suppressor of tumour cell invasion 136 .
Conclusions and future directions
Although previously unappreciated, it now seems obvi ous that actindriven cell motility requires genomic support. Several independent mechanisms can now be outlined that communicate the dynamic status of the actin cytoskeleton to the genome. Microfilamentto genome communication is mediated by different courier proteins, representing GABPs, FABPs or FACAPs, the cytoplasmic release of which for nuclear translocation is dependent on changes in Gactin levels or Factin struc ture and composition. Such courier proteins can func tion inside nuclei as transcriptional cofactors, as clearly shown for the CRP, FHL2, JMy and MRTF proteins. The control of SRF activity by multiple cofactor interactions and signalling inputs serves as a paradigm for under standing the logic of connecting genome activity with actin cytoskeletal dynamics. The intimate functional link between actin dynamics, MRTF-SRFregulated gene expression and cellular motile behaviour has been confirmed by genetic means in several cell and organ systems, including embryonic stem cells 48 , the devel oping mouse embryo 73, 116, 137 , muscle tissues 82, 138 and the brain 11, 139, 140 . However, numerous molecular details of the regulatory interactions involved remain to be worked out in the MRTF-SRF circuit and in all the other abovementioned systems.
We anticipate that new actindependent courier pro teins will be identified. For each relay system it will be important to characterize comprehensively the associ ated differential gene expression profiles. The example of MRTF-SRFdirected expression of miRnAencoding genes indicates that surprising mechanistic insight is to be derived from future studies in this area of cell biology.
Microbial pathogens, both bacteria (for example, Listeria Spp., Samonella Spp. and enteropathogenic Escherichia coli) and viruses (for example, vaccinia virus), subvert actin cytoskeletal functions of the infected host cell by modulating its actin dynamics (for review see REF. 141) . it is likely that these influences on micro filament remodelling are accompanied by changes in gene activity and we postulate that this involves the MRTF-SRF cir cuit. it is equally possible that other, hitherto undetec ted, GABPs might be involved in such events of host cell infection. in more general terms, actin dynamics might communicate to the genome and thereby combat other cellular insults, as already seen in the context of uvinduced DnA damage.
vesicle trafficking such as endocytosis, exocytosis and Golgitoendoplasmic reticulum transport, which are dependent on dynamic actin rearrangements, might also elicit and even require changes in gene expression. This poorly studied aspect of membrane trafficking war rants closer investigation and may offer surprising new insights.
embryonic development requires cell movement and motile functions at many essential steps. The precise contributions of microfilamenttogenome communica tion to these activities are still inadequately understood. Although participation of SRF in mouse gastrulation was noticed early on 73 , the MRTF-SRF circuit is expected to contribute to development in many additional ways, including enabling functions during eMT 22 and stem cell programming and reprogramming 117 . Deeper insight into these issues will prove rewarding.
The remarkable progress in identifying actindependent SRF cofactors and determining their mechanisms of action has provided new insights into the myriad aspects of cell physiology, development and disease. Given the likely involvement of the actin-MRTF-SRF pathway in tissue remodelling during disease, it will be important to determine how this and similar pathways of cytoskeleton tonucleus communication can be therapeutically modulated.
